Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents for evaluation of a main-duct IPMN (MD-IPMN) identified on imaging. Patient reports [asymptomatic / abdominal pain / jaundice / weight loss / steatorrhea]. Main pancreatic duct (MPD) dilation noted at [X] mm. No history of acute pancreatitis. No known family history of pancreatic malignancy.
Clinical Examination Findings
Abdominal examination: Soft, non-tender, non-distended. No palpable masses or organomegaly. Bowel sounds present. Jaundice status: [Scleral icterus present/absent]. Skin: [No signs of cachexia/pallor]. Vital signs stable.
Treatment Protocol
Plan: 1. Surgical consultation for potential resection given MD-IPMN diagnosis. 2. EUS-FNA for cyst fluid analysis (CEA, amylase, cytology) if indicated. 3. Serial surveillance imaging (MRI/MRCP) per international consensus guidelines (Fukuoka/AGA). 4. Management of exocrine insufficiency with pancreatic enzyme replacement therapy (PERT) if symptoms present.